Dr. Harley J Hammerman, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 11615 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-993-9555 Fax: 314-993-9550 |
News Archive
The growing number and costs of drugs for rare diseases (orphan drugs) are straining healthcare budgets. Should the NHS continue to pay for them and how will this affect other health services, ask two articles in this week's British Medical Journal (BMJ)?
AMGEN today announced additional results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF).
Achalasia is a rare disease - it affects 1 in 100,000 people - characterized by a loss of nerve cells in the esophageal wall.
When human cells are exposed to titanium dioxide without the presence of UV light from the sun, the risk for bacterial infection more than doubles. This finding by a Stony Brook University-led research team, published early online in the Journal of Nanobiotechnology, raises concerns about exposure to titanium dioxide, a nanoparticle commonly used in millions of products worldwide ranging from cosmetics to toothpaste, gum, food coloring, and medicines.
Labour warned that the health secretary, Andrew Lansley was still planning to create a "full-scale market" after Steve Field acknowledged that the government would leave hospitals vulnerable to European Union competition law due to the presence of private patients in NHS hospitals.
› Verified 1 days ago